A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia.

Autor: Blume-Peytavi U, Lönnfors S, Hillmann K, Garcia Bartels N
Zdroj: Journal of the American Academy of Dermatology; May2012, Vol. 66 Issue 5, p794-800, 7p
Databáze: Supplemental Index